Enhancing Motivation To Quit Smoking In Smokers With Serious Mental Illness

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2012 by Rutgers, The State University of New Jersey.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Rutgers, The State University of New Jersey ( University of Medicine and Dentistry of New Jersey )
ClinicalTrials.gov Identifier:
NCT00500695
First received: July 12, 2007
Last updated: September 4, 2013
Last verified: July 2012
  Purpose

This project will assess the utility of a brief motivational intervention to engage smokers with schizophrenia in treatment for tobacco dependence treatment. It is hypothesized that a brief motivational intervention will be more effective in engaging smokers with schizophrenia to tobacco dependence treatment than an educational intervention. The educational intervention will increase the likelihood to reducing cigarette intake and/or attending tobacco dependence treatment by teaching subjects about the negative effects of smoking and the success of tobacco dependence treatment. The motivational intervention will increase the likelihood to reducing cigarette intake and/or attending tobacco dependence treatment by increasing subjects' motivation to change by presenting objective and personalized information regarding their smoking behaviors in a non-judgmental and supportive manner.


Condition Intervention Phase
Schizophrenia
Schizoaffective Disorder
Behavioral: Motivational Interviewing
Behavioral: Psychoeducation
Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Enhancing Motivation To Quit Smoking In Smokers With Serious Mental Illness

Resource links provided by NLM:


Further study details as provided by Rutgers, The State University of New Jersey:

Primary Outcome Measures:
  • Attendance at first smoking cessation session [ Time Frame: one month ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Cigarettes per day [ Time Frame: 1-Month Follow Up ] [ Designated as safety issue: No ]

Estimated Enrollment: 100
Study Start Date: May 2006
Estimated Study Completion Date: October 2013
Estimated Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Motivational Interviewing
Motivational Interviewing
Behavioral: Motivational Interviewing
Motivational Interviewing
Active Comparator: Psychoeducation
Psychoeducation
Behavioral: Psychoeducation
Psychoeducation

Detailed Description:

See Brief Summary above.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Current smokers must be over the age of 18,
  • Must have a diagnosis of schizophrenia or schizoaffective disorder
  • Must smoke at least 10 cigarettes per day
  • Must be capable of giving informed consent as measured by Folstein Mini Mental Status Exam of at least 22

Exclusion Criteria:

•Those unable to give informed consent.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00500695

Locations
United States, New Jersey
UMDNJ- Robert Wood Johnson Medical School
New Brunswick, New Jersey, United States, 08901
Sponsors and Collaborators
University of Medicine and Dentistry of New Jersey
Investigators
Principal Investigator: Marc L. Steinberg, PH.D. Rutgers, The State University of New Jersey
  More Information

No publications provided

Responsible Party: Rutgers, The State University of New Jersey ( University of Medicine and Dentistry of New Jersey )
ClinicalTrials.gov Identifier: NCT00500695     History of Changes
Other Study ID Numbers: K23DA018203, K23DA018203
Study First Received: July 12, 2007
Last Updated: September 4, 2013
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Schizophrenia
Psychotic Disorders
Mental Disorders
Schizophrenia and Disorders with Psychotic Features

ClinicalTrials.gov processed this record on September 30, 2014